Inhaled vilanterol trifenatate/fluticasone furoate increases maximum diaphragm contraction in severe COPD

J. Jagers, M. Ji, M. Johnson, E. Wilde, P. Easton (Calgary, Canada; Uxbridge, United Kingdom)

Source: International Congress 2014 – Clinical physiology and respiratory muscles
Session: Clinical physiology and respiratory muscles
Session type: Poster Discussion
Number: 3538
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Jagers, M. Ji, M. Johnson, E. Wilde, P. Easton (Calgary, Canada; Uxbridge, United Kingdom). Inhaled vilanterol trifenatate/fluticasone furoate increases maximum diaphragm contraction in severe COPD. Eur Respir J 2014; 44: Suppl. 58, 3538

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of inhaled vilanterol trifenatate/fluticasone furoate on breathing pattern, dyspnea and respiratory muscle function in severe COPD
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014

Inhaled vilanterol trifenatate/fluticasone furoate (VFF) improves respiratory muscle function and walking performance in severe COPD without change in pulmonary function
Source: International Congress 2017 – Management of COPD
Year: 2017

Effect of vilanterol trifenatate/fluticasone furoate on parasternal raw EMG in severe COPD: Turns analysis
Source: International Congress 2014 – Clinical physiology and respiratory muscles
Year: 2014

Inhaled beta-agonist does not modify sympathetic activity in patients with COPD
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014


Influence of reduced airway patency and respiratory muscle strength on autonomic cardiac modulation in COPD patients
Source: International Congress 2016 – Quality and quantity in lung function
Year: 2016

The functional state of the diaphragm in COPD patients with hypoxemia
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016


Association between dynamic hyperinflation and emphysema distribution in COPD patients
Source: International Congress 2014 – Mechanisms of exercise limitation in disease
Year: 2014



Respiratory impedance by forced oscillation of multi-frequencies technique in asthma with and without airflow obstruction and COPD with and without emphysema
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014


The relation between hyperinflation and daily activity in COPD patients
Source: International Congress 2014 – Clinical exercise physiology in health and COPD
Year: 2014


Morpho-mathematic biomarkers of bronchodilators' response in COPD patients during resting spontaneous breathing
Source: International Congress 2014 – Clinical physiology and respiratory muscles
Year: 2014

Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015

The effects of salmeterol on respiratory muscle activity and ventilatory mechanics in poorly reversible COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 209s
Year: 2003

Small airway dysfunction is associated to the excessive bronchoconstriction in asthma
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014

Exertional dyspnoea, dynamic hyperinflation and respiratory muscle function in idiopathic pulmonary arterial hypertension (PAHi)
Source: International Congress 2014 – Mechanisms of exercise limitation in health and disease
Year: 2014


Neural respiratory drive (NRD) measured by parasternal electromyography predicts clinical deterioration and early readmission in patients with acute exacerbation of COPD (AECOPD)
Source: International Congress 2014 – Respiratory pathophysiology: mechanisms of alteration of lung, respiratory and peripheral muscle function
Year: 2014

Improvement in airflow obstruction with inhaled bronchodilators influences the pattern of abdominal muscle recruitment during exercise in COPD
Source: Annual Congress 2010 - Thoracic dynamics and dyspnoea on exercise
Year: 2010


Inspiratory capacity manoeuvres may underestimate dynamic hyperinflation in patients with COPD; the explanation for apparent non-inflators
Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Year: 2016

Neuromuscular dissociation of the diaphragm is more pronounced during treadmill exercise compared with cycle exercise in obese COPD patients
Source: International Congress 2014 – Clinical physiology and respiratory muscles
Year: 2014

Effect of short-acting bronchodilators (BDs) on the severity of respiratory muscle (RM) strength in COPD patients (pts)
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Effects of inspiratory muscle training and respiratory exercise at muscle function, thoracoabdominal mobility and dyspnea in patients with COPD
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment methods in COPD and asthma
Year: 2013